Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c48f963389b9bbf8d3940d2b0f2940 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
filingDate |
2012-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_993909cb5acf886dc54053e474f92e81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f880147b24affed98c6d997c0fa9ceb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_047a57b66624002f96cbdd53f59726a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_904e1fc3b5c2ff2785ae6ec243778707 |
publicationDate |
2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2012255797-A |
titleOfInvention |
Improved immunoassay method |
abstract |
A diagnostic or prognostic assay using biological markers of disease state or disease susceptibility is provided. (A) Two or more different dilutions of a test sample are prepared, and for each test sample dilution, the following steps (i) and (ii): (i) the test sample dilution is specific to the antibody. Performing a step of contacting a plurality of different amounts of antigen, (ii) detecting the amount of specific binding of the antibody to the antigen for each antigen amount used in step (i); (b) ) Plotting or calculating a specific curve of specific binding versus antigen for each test sample dilution used in step (a); and (c) antibody and antigen specific for each test sample dilution. Determining the presence or absence of a disease state or disease susceptibility based on the amount of binding and the amount of test antigen. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014167469-A |
priorityDate |
2006-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |